Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Elpis Biopharmaceuticals

Elpis Biopharmaceuticals is a biotechnology company developing immunotherapies for treating cancer.

Overview Structured Data Issues Contributors Activity

elpisbiopharmaceuticals.com

Is a

Company

Organization

Company attributes

Industry

...

Location

Lexington, Massachusetts

CEO

Yan Chen

Date Incorporated

2017

Email Address

bd@elpisbiopharm.com0

hr@elpisbiopharm.com0

Full Address

128 Spring St. Lexington, MA 02421

Founded Date

2017

Country

United States

Other attributes

Company Operating Status

Active

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

Luye expanding I-O deal with U.S. firm Elpis to focus on CAR T therapies

Luye Pharma

https://www.prnewswire.com/news-releases/luye-expanding-i-o-deal-with-us-firm-elpis-to-focus-on-car-t-therapies-300661517.html

Web

Luye to Continue Work with Elpis to Develop New CAR-T Therapies

Don McCormick

https://www.biospace.com/article/luye-to-continue-work-with-elpis-to-develop-new-car-t-therapies/

Web

References

Find more companies like Elpis Biopharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API